Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
2013 participants
OBSERVATIONAL
2004-03-31
2007-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
AV Node Ablation and Pacemaker Therapy Compared to Drug Therapy for Atrial Fibrillation - Pilot Study
NCT00589303
Device-detected Paroxysmal Atrial Fibrillation
NCT02442505
Prospective Evaluation of Open Irrigated Ablation Catheters With High Resolution Mapping to Treat Paroxysmal Atrial Fibrillation
NCT03729830
PROTECT-PACE STUDY - The Protection of Left Ventricular Function During Right Ventricular Pacing
NCT00461734
Electrophysiologically Guided PAcing Site Selection Study
NCT00239226
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient implanted with one of the following market-approved single or dual chamber Medtronic devices: EnRhythm™, EnPulse®, Kappa® 700, Kappa® 900, Vitatron Clarity™, Vitatron Selection® AFm, Vitatron C-Series, Vitatron T-Series, or the AT500™ DDDR Pacing System
Exclusion Criteria
* Patient whose life expectancy is less than two years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic Cardiac Rhythm and Heart Failure
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Medtronic CRDM
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ravi Kanagala, MD
Role: STUDY_CHAIR
Franciscan Skemp Healthcare
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Birmingham, Alabama, United States
Prescott, Arizona, United States
Little Rock, Arkansas, United States
Aliso Viejo, California, United States
Anaheim, California, United States
Arcadia, California, United States
Escondido, California, United States
Fountain Valley, California, United States
La Mesa, California, United States
Laguna Hills, California, United States
Mission Viejo, California, United States
Orange, California, United States
Riverside, California, United States
Tarzana, California, United States
Whittier, California, United States
Wildomar, California, United States
Denver, Colorado, United States
Fort Lauderdale, Florida, United States
Lauderdale Lakes, Florida, United States
Melbourne, Florida, United States
Ocala, Florida, United States
Sarasota, Florida, United States
Vero Beach, Florida, United States
Lawrenceville, Georgia, United States
Idaho Falls, Idaho, United States
Hinsdale, Illinois, United States
Moline, Illinois, United States
Hammond, Indiana, United States
Terre Haute, Indiana, United States
Hutchinson, Kansas, United States
Edgewood, Kentucky, United States
Owensboro, Kentucky, United States
Lafayette, Louisiana, United States
New Orleans, Louisiana, United States
Shreveport, Louisiana, United States
Scarborough, Maine, United States
Rockville, Maryland, United States
Boston, Massachusetts, United States
Cambridge, Massachusetts, United States
Alpena, Michigan, United States
Cleveland, Mississippi, United States
Moberly, Missouri, United States
Osage Beach, Missouri, United States
Saint Joseph, Missouri, United States
St Louis, Missouri, United States
Billings, Montana, United States
Kearney, Nebraska, United States
Omaha, Nebraska, United States
Bridgewater, New Jersey, United States
Clifton, New Jersey, United States
Elizabeth, New Jersey, United States
Galloway, New Jersey, United States
Elmira, New York, United States
Huntington, New York, United States
Charlotte, North Carolina, United States
Durham, North Carolina, United States
Cincinnati, Ohio, United States
Cleveland, Ohio, United States
Cleveland Heights, Ohio, United States
Columbus, Ohio, United States
Dublin, Ohio, United States
Kettering, Ohio, United States
Lima, Ohio, United States
Lorain, Ohio, United States
Mayfield Heights, Ohio, United States
Middleburg Heights, Ohio, United States
Zanesville, Ohio, United States
Tulsa, Oklahoma, United States
Wakefield, Rhode Island, United States
Greenville, South Carolina, United States
Sumter, South Carolina, United States
Austin, Texas, United States
Beaumont, Texas, United States
Houston, Texas, United States
Humble, Texas, United States
Lubbock, Texas, United States
McAllen, Texas, United States
San Antonio, Texas, United States
Tomball, Texas, United States
Victoria, Texas, United States
Wichita Falls, Texas, United States
La Crosse, Wisconsin, United States
Waukesha, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
244
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.